Benson Investment Management Company Inc. bought a new stake in shares of Genpact Limited (NYSE:G - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 60,073 shares of the business services provider's stock, valued at approximately $2,644,000.
Other institutional investors have also added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. boosted its position in Genpact by 59.2% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock valued at $522,000 after buying an additional 3,849 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in Genpact by 20.6% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock valued at $486,000 after buying an additional 1,651 shares during the period. Wright Investors Service Inc. purchased a new stake in Genpact during the 2nd quarter valued at $457,000. GAMMA Investing LLC boosted its position in Genpact by 88.0% during the 1st quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock valued at $491,000 after buying an additional 4,561 shares during the period. Finally, Assenagon Asset Management S.A. purchased a new stake in Genpact during the 1st quarter valued at $2,396,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Genpact Trading Down 2.1%
NYSE:G opened at $39.35 on Friday. The company has a 50-day moving average price of $42.97 and a 200-day moving average price of $44.60. Genpact Limited has a 12 month low of $37.82 and a 12 month high of $56.76. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.32. The stock has a market cap of $6.86 billion, a price-to-earnings ratio of 13.07, a P/E/G ratio of 1.38 and a beta of 0.89.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.03. The company had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.23 billion. Genpact had a net margin of 10.92% and a return on equity of 22.15%. Genpact's quarterly revenue was up 6.6% compared to the same quarter last year. During the same period last year, the business earned $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Equities analysts predict that Genpact Limited will post 3.21 EPS for the current year.
Genpact Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, December 9th. Genpact's dividend payout ratio (DPR) is presently 22.59%.
Analysts Set New Price Targets
Several brokerages have weighed in on G. Weiss Ratings reissued a "hold (c)" rating on shares of Genpact in a research report on Wednesday. Deutsche Bank Aktiengesellschaft began coverage on shares of Genpact in a research report on Thursday, July 17th. They set a "hold" rating and a $47.00 price target for the company. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Needham & Company LLC raised their target price on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research report on Wednesday, August 20th. Three analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $52.29.
View Our Latest Report on G
Insider Activity
In related news, SVP Piyush Mehta sold 76,902 shares of the stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total value of $3,274,487.16. Following the completion of the transaction, the senior vice president directly owned 134,880 shares in the company, valued at $5,743,190.40. This trade represents a 36.31% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the transaction, the chief executive officer owned 295,246 shares of the company's stock, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is owned by company insiders.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.